Heppe Medical Chitosan GmbH is a German chitosan producer for the worldwide medical technology and pharmaceutical industry. Established in 2005, HMC is an ISO 9001 and ISO13485 certified company, working in line with EU-GMP guidelines. They specialize in producing chitosan and chitosan derivatives in Germany. The company also offers custom manufacturing of chitosan specialities and can synthesize special chitosan derivatives upon request. Heppe Medical Chitosan GmbH operates in the Biotechnology, Health Care, and Manufacturing industries. The latest notable investment was a Series B round received on 28 October 2010, with participation from KI Kapital and HTGF (High-Tech Gruenderfonds). This investment further signifies the confidence and support from the investor community in the company's potential for growth and advancements in the medical and pharmaceutical sectors.
No recent news or press coverage available for Heppe Medical Chitosan GmbH.